9ZQ-20660-51829
3 vaccinations
13 coded responses
25 check-ins
13 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tirednessFree text: Fuzzyheadedness- Im having trouble keeping everything together todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal — Feeling: Good · Fatigue or tirednessFree text: FuzziheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
-
2021-03-12
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · DiarrheaFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: Good · DiarrheaFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-03-29
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Good · Joint painsFree text: FuzzyheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Joint pains, Fatigue or tirednessFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — day 7, dose 2MedDRA: Mood swings — Feeling: Fair · Fatigue or tirednessFree text: Mood swingsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-19
-
2021-04-26
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Not new, but the fatigue continues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
- 2021-05-10
- 2021-06-28
-
2021-08-30
Dose 3 — Pfizer-BioNTech
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Electrocardiogram QT prolonged, Office visit, Pre-existing disease, Urticaria — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Symptoms: Atherosclerosis, uncontrolled high BP despite taking meds every day, prolonged QT, sleep apnea, urticaria attack on arms, sides, stomach that lasted for three weeks & required 6 ceritizine a day & topical steroid cream for 10 days to get rid of · Healthcare visit (other): In person w doctorMedDRA releases: 2024-11 · check-in free text available
-
2021-09-27
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2021-09-30
- 2022-03-29
- 2022-08-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Fuzzyheadedness- Im having trouble keeping everything together today
Systemic reaction (other): Fuzziheadedness
Systemic reaction (other): None
Systemic reaction (other): None
Systemic reaction (other): None
Release 5 — day 7, dose 1
Systemic reaction (other): None
Release 6 — day 0, dose 2
Systemic reaction (other): None
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Fuzzyheadedness
Systemic reaction (other): None
Systemic reaction (other): None
Release 6 — day 7, dose 2
Systemic reaction (other): Mood swings
Release 8 — day 28, dose 2
Symptoms: Not new, but the fatigue continues.
Release 9 — 6 months, dose 2
Symptoms: Atherosclerosis, uncontrolled high BP despite taking meds every day, prolonged QT, sleep apnea, urticaria attack on arms, sides, stomach that lasted for three weeks & required 6 ceritizine a day & topical steroid cream for 10 days to get rid of
Healthcare visit (other): In person w doctor
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Electrocardiogram QT prolonged | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Mood swings | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release